179 related articles for article (PubMed ID: 35209822)
1. Increase in Cisplatin Resistance by MeCP2 in Human Gastric Cancer through the Activation of the AKT Pathway by Facilitating PDK-1 Transcription.
Guo B; Cai S; Li W; Guo C; Liu Y; Ma X; Ma H; Zhao L
Curr Cancer Drug Targets; 2022; 22(5):414-425. PubMed ID: 35209822
[TBL] [Abstract][Full Text] [Related]
2. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p.
Wang X; Zhang Y; Li W; Liu X
J Surg Res; 2021 May; 261():185-195. PubMed ID: 33444948
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.
Deng P; Sun M; Zhao WY; Hou B; Li K; Zhang T; Gu F
World J Gastroenterol; 2021 Feb; 27(6):487-500. PubMed ID: 33642823
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
7. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
[TBL] [Abstract][Full Text] [Related]
8. CAF-derived midkine promotes EMT and cisplatin resistance by upregulating lncRNA ST7-AS1 in gastric cancer.
Yang KD; Wang Y; Zhang F; Li QL; Luo BH; Feng DY; Zeng ZJ
Mol Cell Biochem; 2022 Nov; 477(11):2493-2505. PubMed ID: 35588343
[TBL] [Abstract][Full Text] [Related]
9. The Zuo Jin Wan Formula increases chemosensitivity of human primary gastric cancer cells by AKT mediated mitochondrial translocation of cofilin-1.
Sun MY; Wang DD; Sun J; Zhao XH; Cai S; Wu QX; Jie T; Ni ZH; Sun JY; Tang QF
Chin J Nat Med; 2019 Mar; 17(3):198-208. PubMed ID: 30910056
[TBL] [Abstract][Full Text] [Related]
10. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
11. Linc00852 from cisplatin-resistant gastric cancer cell-derived exosomes regulates COMMD7 to promote cisplatin resistance of recipient cells through microRNA-514a-5p.
Cao S; Fu B; Cai J; Zhang D; Wang C; Wu H
Cell Biol Toxicol; 2023 Apr; 39(2):483-496. PubMed ID: 35088190
[TBL] [Abstract][Full Text] [Related]
12. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
Zhou X; Jin W; Jia H; Yan J; Zhang G
J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
[TBL] [Abstract][Full Text] [Related]
13. Depletion of circPDSS1 inhibits ITGA11 production to confer cisplatin sensitivity through miR-515-5p in gastric cancer.
Wang Y; Tang S; Li L; Sun C; Liu Y; Zhao Y
J Chemother; 2023 Oct; 35(6):514-526. PubMed ID: 36484486
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of LINC01857 Increases Sensitivity of Gastric Carcinoma Cells to Cisplatin.
Chen Y; Wu Y
Comput Math Methods Med; 2022; 2022():3325686. PubMed ID: 35602347
[TBL] [Abstract][Full Text] [Related]
15. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.
Ni Q; Zhang Y; Tao R; Li X; Zhu J
Aging (Albany NY); 2021 Mar; 13(6):8665-8687. PubMed ID: 33714198
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress‑mediated apoptosis and G2/M phase arrest.
Ren M; Zhou X; Gu M; Jiao W; Yu M; Wang Y; Liu S; Yang J; Ji F
Oncol Rep; 2020 Oct; 44(4):1605-1615. PubMed ID: 32945472
[TBL] [Abstract][Full Text] [Related]
18. MiR-874-3p represses the migration and invasion yet promotes the apoptosis and cisplatin sensitivity via being sponged by long intergenic non-coding RNA 00922 (LINC00922) and targeting Glycerophosphodiester Phosphodiesterase Domain Containing 5 (GDPD5) in gastric cancer cells.
Zhang X; Dai X; Zhao X; Wang J; Dou J; Zhuang H; Chen N; Zhao H
Bioengineered; 2022 Mar; 13(3):7082-7104. PubMed ID: 35282764
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
[TBL] [Abstract][Full Text] [Related]
20. Silencing of miR-1246 Induces Cell Cycle Arrest and Apoptosis in Cisplatin-Resistant Ovarian Cancer Cells by Promoting ZNF23 Transcription.
Cai L; Zhang Q; Du L; Zheng F
Cytogenet Genome Res; 2021; 161(10-11):488-500. PubMed ID: 34923485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]